Published in J Virol on January 01, 2000
Multiple groups of novel retroviral genomes in pigs and related species. J Virol (2001) 1.67
Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine. J Virol (2002) 1.53
Identification of receptors for pig endogenous retrovirus. Proc Natl Acad Sci U S A (2003) 1.23
Establishment and characterization of molecular clones of porcine endogenous retroviruses replicating on human cells. J Virol (2000) 1.19
Identification of novel porcine endogenous betaretrovirus sequences in miniature swine. J Virol (2001) 1.18
Evidence and consequence of porcine endogenous retrovirus recombination. J Virol (2004) 1.10
Characterization of chromosomally assigned replication-competent gamma porcine endogenous retroviruses derived from a large white pig and expression in human cells. J Virol (2002) 1.09
Absence of replication-competent human-tropic porcine endogenous retroviruses in the germ line DNA of inbred miniature Swine. J Virol (2004) 1.09
Comparison of replication-competent molecular clones of porcine endogenous retrovirus class A and class B derived from pig and human cells. J Virol (2001) 1.07
Mapping full-length porcine endogenous retroviruses in a large white pig. J Virol (2001) 1.04
Determinants of high titer in recombinant porcine endogenous retroviruses. J Virol (2004) 1.04
Study of full-length porcine endogenous retrovirus genomes with envelope gene polymorphism in a specific-pathogen-free Large White swine herd. J Virol (2000) 1.03
Infection of nonhuman primate cells by pig endogenous retrovirus. J Virol (2000) 1.02
Porcine endogenous retrovirus integration sites in the human genome: features in common with those of murine leukemia virus. J Virol (2006) 0.99
Porcine endogenous retrovirus infects but does not replicate in nonhuman primate primary cells and cell lines. J Virol (2002) 0.98
Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses. Clin Microbiol Rev (2012) 0.97
Susceptibility of the porcine endogenous retrovirus to reverse transcriptase and protease inhibitors. J Virol (2001) 0.95
Characterizing and mapping porcine endogenous retroviruses in Westran pigs. J Virol (2002) 0.94
Detection and characterization of porcine endogenous retrovirus in porcine plasma and porcine factor VIII. J Virol (2001) 0.93
Sequence analysis of porcine endogenous retrovirus long terminal repeats and identification of transcriptional regulatory regions. J Virol (2003) 0.88
Identification of residues outside of the receptor binding domain that influence the infectivity and tropism of porcine endogenous retrovirus. J Virol (2008) 0.86
Mice transgenic for a human porcine endogenous retrovirus receptor are susceptible to productive viral infection. J Virol (2006) 0.86
Human CD59 incorporation into porcine endogenous retrovirus particles: implications for the use of transgenic pigs for xenotransplantation. J Virol (2002) 0.85
Porcine endogenous retroviruses infect cells lacking cognate receptors by an alternative pathway: implications for retrovirus evolution and xenotransplantation. J Virol (2004) 0.84
Comparison of the convergent receptor utilization of a retargeted feline leukemia virus envelope with a naturally-occurring porcine endogenous retrovirus A. Virology (2012) 0.84
Feline immunodeficiency virus xenoinfection: the role of chemokine receptors and envelope diversity. J Virol (2002) 0.83
Differential resistance to cell entry by porcine endogenous retrovirus subgroup A in rodent species. Retrovirology (2007) 0.83
Porcine endogenous retroviruses in xenotransplantation--molecular aspects. Viruses (2014) 0.81
Porcine endogenous retroviruses PERV A and A/C recombinant are insensitive to a range of divergent mammalian TRIM5alpha proteins including human TRIM5alpha. J Gen Virol (2009) 0.81
Influence of chitosan nanofiber scaffold on porcine endogenous retroviral expression and infectivity in pig hepatocytes. World J Gastroenterol (2011) 0.80
Characterization of two porcine endogenous retrovirus integration loci and variability in pigs. Immunogenetics (2003) 0.80
Porcine endogenous retrovirus transmission characteristics of galactose alpha1-3 galactose-deficient pig cells. J Virol (2004) 0.80
Retroviral restriction factors and infectious risk in xenotransplantation. Am J Transplant (2010) 0.79
Functional hierarchy of two L domains in porcine endogenous retrovirus (PERV) that influence release and infectivity. Virology (2008) 0.79
Identification of two distinct structural regions in a human porcine endogenous retrovirus receptor, HuPAR2, contributing to function for viral entry. Retrovirology (2009) 0.79
Quantitative analysis of porcine endogenous retroviruses in different organs of transgenic pigs generated for xenotransplantation. Curr Microbiol (2013) 0.78
Suboptimal porcine endogenous retrovirus infection in non-human primate cells: implication for preclinical xenotransplantation. PLoS One (2010) 0.77
Immune modulation in xenotransplantation. Arch Immunol Ther Exp (Warsz) (2014) 0.76
Susceptibility of porcine endogenous retrovirus to anti-retroviral inhibitors. Xenotransplantation (2016) 0.76
Molecular and enzymatic characterization of the porcine endogenous retrovirus protease. J Virol (2002) 0.75
Review on porcine endogenous retrovirus detection assays--impact on quality and safety of xenotransplants. Xenotransplantation (2015) 0.75
Characterization of insertional variation of porcine endogenous retroviruses in six different pig breeds. Asian-Australas J Anim Sci (2012) 0.75
Polymerase chain reaction in detection of porcine endogenous retrovirus (PERV) from porcine tissues. Indian J Microbiol (2009) 0.75
Extended Microbiological Characterization of Göttingen Minipigs in the Context of Xenotransplantation: Detection and Vertical Transmission of Hepatitis E Virus. PLoS One (2015) 0.75
Infection of human cells by an endogenous retrovirus of pigs. Nat Med (1997) 5.71
TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J Immunol (1985) 3.18
Host range and interference studies of three classes of pig endogenous retrovirus. J Virol (1998) 2.94
Two sets of human-tropic pig retrovirus. Nature (1997) 2.74
Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol (1998) 2.59
Viral and cellular factors governing hamster cell infection by murine and gibbon ape leukemia viruses. J Virol (1991) 2.18
Identification of a full-length cDNA for an endogenous retrovirus of miniature swine. J Virol (1998) 2.10
Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet (1998) 2.06
Characterization of a type C virus released from the porcine cell line PK(15). Virology (1974) 1.81
C-type virus particles in pig kidney cell lines. J Gen Virol (1971) 1.67
Factors affecting retroviral vector function and structural integrity. Virology (1993) 1.59
Comparison of cDNAs encoding the gibbon ape leukaemia virus receptor from susceptible and non-susceptible murine cells. J Gen Virol (1994) 1.56
Phenotypic mixing between avian and mammalian RNA tumor viruses: I. Envelope pseudotypes of Rous sarcoma virus. Virology (1977) 1.37
Biologic and immunologic properties of porcine type C viruses. Virology (1975) 1.28
Oncogenicity of gibbon type-C myelogenous leukemia virus. Int J Cancer (1980) 1.08
Suppression of the hypomethylated Moloney leukemia virus genome in undifferentiated teratocarcinoma cells and inefficiency of transformation by a bacterial gene under control of the long terminal repeat. Mol Cell Biol (1985) 1.07
Selection of an avian retrovirus mutant with extended receptor usage. J Virol (1997) 1.05
Entry of amphotropic murine leukemia virus is influenced by residues in the putative second extracellular domain of its receptor, Pit2. J Virol (1998) 1.02
Role of proliferation in LAK cell development. Cancer Immunol Immunother (1988) 0.94
Porcine endogenous retrovirus is transmitted neither in vivo nor in vitro from porcine endothelial cells to baboons. Transplant Proc (1999) 0.92
The Biomolecular Interaction Network Database and related tools 2005 update. Nucleic Acids Res (2005) 12.94
The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med (2001) 11.48
A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias. N Engl J Med (2013) 6.67
The unmet health needs of America's children. Pediatrics (2000) 3.45
A randomized controlled trial of surgery vs steroid injection for carpal tunnel syndrome. Neurology (2005) 3.26
The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors. Virology (1998) 2.96
Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart (2002) 2.83
Mechanical function of dystrophin in muscle cells. J Cell Biol (1995) 2.67
Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol (1992) 2.63
Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol (1998) 2.59
Acoustic characteristics of English fricatives. J Acoust Soc Am (2000) 2.30
Accumulation of enoxacin by Escherichia coli and Bacillus subtilis. Antimicrob Agents Chemother (1987) 2.26
Molecular heterogeneity of the fragile X syndrome. Nucleic Acids Res (1991) 2.00
Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori. Antimicrob Agents Chemother (1995) 1.94
The use of alternative therapies by Auckland general practitioners. N Z Med J (1990) 1.89
Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1984) 1.88
Linking the Rb and polycomb pathways. Mol Cell (2001) 1.76
Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys (1998) 1.72
Transcriptional regulation of oxytocin receptor by interleukin-1beta and interleukin-6. Endocrinology (2001) 1.65
Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome. Neurology (2011) 1.64
Molecular characterization of bovine enteric caliciviruses: a distinct third genogroup of noroviruses (Norwalk-like viruses) unlikely to be of risk to humans. J Virol (2003) 1.64
Attitudes and beliefs about organ donation among different racial groups. J Natl Med Assoc (1998) 1.60
Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education. Pharmacogenomics J (2005) 1.53
Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers. Tob Control (2004) 1.47
Metal-dependent binding of a factor in vivo to the metal-responsive elements of the metallothionein 1 gene promoter. Mol Cell Biol (1987) 1.47
Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-kappaB-independent mechanism. FASEB J (2005) 1.47
Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med (1996) 1.46
Killer whale (Orcinus orca) hearing: auditory brainstem response and behavioral audiograms. J Acoust Soc Am (1999) 1.43
Multiple myeloma presenting with acute disseminated encephalomyelitis: causal or chance link? Neurology (2006) 1.42
Outcome of an institutional sexual offender treatment program: a comparison between treated and matched untreated offenders. Sex Abuse (2000) 1.41
Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei. Can J Infect Dis (1994) 1.38
Pseudomonas pseudomallei resistance to beta-lactam antibiotics due to alterations in the chromosomally encoded beta-lactamase. Antimicrob Agents Chemother (1991) 1.37
Categorization of clinical isolates of Helicobacter pylori on the basis of restriction digest analyses of polymerase chain reaction-amplified ureC genes. J Clin Microbiol (1993) 1.36
Insulin inhibits the cholera-toxin-catalysed ribosylation of a Mr-25000 protein in rat liver plasma membranes. Biochem J (1985) 1.35
Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest (1984) 1.33
Investigation and management of severe hyponatraemia in a hospital setting. Postgrad Med J (2006) 1.31
13C NMR of Nephila clavipes major ampullate silk gland. Biophys J (1996) 1.30
Glucose regulated protein induction and cellular resistance to oxidative stress mediated by porphyrin photosensitization. Cancer Res (1991) 1.30
A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity. J Virol (1994) 1.30
Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins. Cancer Res (1996) 1.28
Establishment of a Chinese hamster ovary cell line that expresses grp78 antisense transcripts and suppresses A23187 induction of both GRP78 and GRP94. J Cell Physiol (1992) 1.27
Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Health Technol Assess (2008) 1.22
Endogenous Nocardia asteroides subretinal abscess diagnosed by transvitreal fine-needle aspiration biopsy. Retina (1989) 1.22
Generation of a life-expanded rhesus monkey fibroblast cell line for the growth of rhesus rhadinovirus (RRV). Arch Virol (2002) 1.22
Should the JT rather than the QT interval be used to detect prolongation of ventricular repolarization? An assessment in normal conduction and in ventricular conduction defects. J Electrocardiol (1992) 1.21
Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory. Immunol Cell Biol (1999) 1.20
Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. J Immunol (1998) 1.20
Towards effective clinical teaching in nursing. J Adv Nurs (1987) 1.20
Curative one-shot systemic virotherapy in murine myeloma. Leukemia (2012) 1.20
Diagnosis of disseminated microsporidian Encephalitozoon hellem infection by PCR-Southern analysis and successful treatment with albendazole and fumagillin. J Clin Microbiol (1996) 1.17
Non-smokers seeking help for smokers: a preliminary study. Tob Control (2006) 1.17
Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity. J Virol (2001) 1.17
Inhibition of PCR by agar from bacteriological transport media. J Clin Microbiol (1998) 1.17
Properties and applications of photodynamic therapy. Radiat Res (1989) 1.17
Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation. Neurogastroenterol Motil (2009) 1.14
Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses. Gene Ther (2012) 1.12
Soluble forms of the subgroup A avian leukosis virus [ALV(A)] receptor Tva significantly inhibit ALV(A) infection in vitro and in vivo. J Virol (1999) 1.09
Cis,cis-muconate lactonizing enzyme from Trichosporon cutaneum: evidence for a novel class of cycloisomerases in eucaryotes. Biochemistry (1994) 1.09
Visual and circadian responses to light in aged retinally degenerate mice. Vision Res (1994) 1.09
Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacin. Antimicrob Agents Chemother (1989) 1.08
A structural basis for reading fluency: white matter defects in a genetic brain malformation. Neurology (2007) 1.08
Construction of stabilized proteins by combinatorial consensus mutagenesis. Protein Eng Des Sel (2004) 1.07
Dendritic cell activation and cytokine production induced by group B Neisseria meningitidis: interleukin-12 production depends on lipopolysaccharide expression in intact bacteria. Infect Immun (2001) 1.07
Pharmacokinetics of oncolytic measles virotherapy: eventual equilibrium between virus and tumor in an ovarian cancer xenograft model. Cancer Gene Ther (2006) 1.07
Regulation of the oncogenic activity of BCR-ABL by a tightly bound substrate protein RIN1. Immunity (1997) 1.07
Glioblastoma multiforme occurring in a patient treated with gamma knife surgery. Case report and review of the literature. J Neurosurg (2001) 1.06
Open mesh repair of incisional hernias with significant loss of domain. Ann R Coll Surg Engl (2004) 1.06
House dust mite induces direct airway inflammation in vivo: implications for future disease therapy? Eur Respir J (2009) 1.06
Common effects of touch and vision on postural parameters. Exp Brain Res (1997) 1.05
Definition of family of coronin-related proteins conserved between humans and mice: close genetic linkage between coronin-2 and CD45-associated protein. DNA Cell Biol (1998) 1.05
PPAR-gamma agonists as therapy for diseases involving airway neutrophilia. Eur Respir J (2004) 1.05
Identification of key residues in subgroup A avian leukosis virus envelope determining receptor binding affinity and infectivity of cells expressing chicken or quail Tva receptor. J Virol (2001) 1.05
BAG3-related myofibrillar myopathy in a Chinese family. Clin Genet (2011) 1.02
Photodynamic therapy mediated induction of early response genes. Cancer Res (1994) 1.01
A prospective study of symptomatic bacteremia following platelet transfusion and of its management. Transfusion (1994) 1.00
Are hereditary hemochromatosis mutations involved in Alzheimer disease? Am J Med Genet (2000) 1.00
Nrg-1 belongs to the endothelial differentiation gene family of G protein-coupled sphingosine-1-phosphate receptors. J Biol Chem (2000) 0.99
Adjuvant therapy for stage III colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group. Cancer Prev Control (1997) 0.98
Quinolone antimicrobial agents: mechanism of action and resistance development. Clin Invest Med (1989) 0.98
Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors. J Pharmacol Exp Ther (2011) 0.98
Orbital and eyelid involvement with Erdheim-Chester disease. A report of two cases. Arch Ophthalmol (1991) 0.97
Epigenetic mechanisms of drug resistance: drug-induced DNA hypermethylation and drug resistance. Proc Natl Acad Sci U S A (1993) 0.97
Regulated tRNA import in Leishmania mitochondria. Biochim Biophys Acta (1998) 0.96
A new defective retroviral vector system based on the Bryan strain of Rous sarcoma virus. Virology (1993) 0.96
CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function. J Virol (1999) 0.96
Evaluation of chronic disease self-management programme (CDSMP) for older adults in Hong Kong. J Nutr Health Aging (2011) 0.96
Familial isolated hyperparathyroidism: a distinct genetic entity with an increased risk of parathyroid cancer. J Clin Endocrinol Metab (1993) 0.96
Pinhole micro-SPECT/CT for noninvasive monitoring and quantitation of oncolytic virus dispersion and percent infection in solid tumors. Gene Ther (2011) 0.95
The disulfide linkages and glycosylation sites of the human natriuretic peptide receptor-C homodimer. Biochemistry (1994) 0.95
Stability of dopamine and epinephrine solutions up to 84 hours. Pediatr Crit Care Med (2001) 0.95
BCR/ABL inhibition by an escort/phosphatase fusion protein. Proc Natl Acad Sci U S A (2000) 0.95
Invariant natural killer (iNK) T cell deficiency in patients with common variable immunodeficiency. Clin Exp Immunol (2009) 0.94
A spectrin-like protein in retinal rod outer segments. Biochemistry (1986) 0.93
Detection and characterization of porcine endogenous retrovirus in porcine plasma and porcine factor VIII. J Virol (2001) 0.93
Vectors and genes for improvement of animal strains. J Reprod Fertil Suppl (1990) 0.93
Selection of a subgroup A avian leukosis virus [ALV(A)] envelope resistant to soluble ALV(A) surface glycoprotein. Virology (2000) 0.93
Changes in 17 beta,20 alpha-hydroxysteroid dehydrogenase activity supporting an increase in the estrogen/progesterone ratio of human fetal membranes at parturition. Am J Obstet Gynecol (1993) 0.93
Screening African-American elderly for the presence of depressive symptoms: a preliminary investigation. J Geriatr Psychiatry Neurol (1996) 0.92